共 267 条
[1]
Sharma SK(2005)HIV-TB coinfection: epidemiology, diagnosis & management Indian J Med Res 121 550-567
[2]
Mohan A(2003)The growing burden of tuberculosis: global trends and interactions with the HIV epidemic Arch Intern Med 163 1009-1021
[3]
Kadhiravan T(1999)Nevirapine induces both CYP3A4 and CYP2B6 metabolic pathways Clin Pharmacol Ther 65 137-373
[4]
Corbett EL(2004)Nevirapine in the treatment of HIV Expert Rev Anti Infect Ther 2 367-431
[5]
Watt CJ(2001)Regulation of the human CYP2B6 gene by the nuclear pregnane X receptor Mol Pharmacol 60 427-857
[6]
Walker N(2001)Rifampin is a selective, pleiotropic inducer of drug metabolism genes in human hepatocytes: studies with cDNA and oligonucleotide expression arrays J Pharmacol Exp Ther 299 849-605
[7]
Maher D(2003)Low nevirapine plasma concentrations predict virological failure in an unselected HIV-1-infected population Clin Pharmacokinet 42 599-970
[8]
Williams BG(1997)High-dose nevirapine in previously untreated human immunodeficiency virus type 1-infected persons does not result in sustained suppression of viral replication J Infect Dis 175 966-41
[9]
Raviglione MC(2006)Increasing nevirapine dose can overcome reduced bioavailability due to rifampicin coadministration J Acquir Immune Defic Syndr 42 36-453
[10]
Dye C(2001)Pharmacokinetic interaction between nevirapine and rifampicin in HIV-infected patients with tuberculosis J Acquir Immune Defic Syndr 28 450-2490